Jupiter Life Line Hospital Limited has announced its earnings conference call to discuss the operational and financial performance for Q3 & 9M FY26. The call is scheduled for February 02, 2026 at 10:00 AM IST and will provide insights into the company's quarterly and nine-month performance.

Conference Call Details

The earnings call will be represented by Dr. Ankit Thakker, Joint Managing Director and CEO, along with the senior management team. The company has issued formal notification to both National Stock Exchange of India Limited and BSE Limited under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Access Information

Investors and analysts interested in participating in the earnings call are required to pre-register through the company's designated registration link. The company has provided multiple access numbers to accommodate participants from different regions.

Regulatory Compliance

The company has fulfilled its regulatory obligations by notifying the stock exchanges about the earnings call. The notification was signed by Suma Upparatti, Company Secretary & Compliance Officer, on January 23, 2026. The earnings call information will also be made available on the company's official website at www.jupiterhospital.com .

Coordination Support

Strategic Growth Advisors Pvt. Ltd. is coordinating the earnings call, with Mandar Chavan and Rahul Agarwal serving as the primary contacts. Participants can reach them at mandar.chavan@sgapl.net or rahul.agarwal@sgapl.net , or through phone numbers 9699382195 and 9821438864 respectively.

Jupiter Life Line Hospital Limited (JLHL) has received a modified order from the National Company Law Tribunal (NCLT) Mumbai Bench regarding its proposed amalgamation with Medulla Healthcare Private Limited. This development marks a step in the company's corporate restructuring process.

Key Points of the Modified NCLT Order

• Creditor Notification: The NCLT has revised its earlier directions, now requiring notice to be served only to unsecured creditors with outstanding amounts exceeding Rs 50,000.
• Unchanged Directives: All other previous directions from the NCLT's earlier order remain in effect.
• Affected Companies: The order pertains to the Scheme of Amalgamation between Medulla Healthcare Private Limited (Transferor Company) and Jupiter LifeLine Hospitals Limited (Transferee Company).

Implications of the Order

This modification may streamline the notification process for the proposed amalgamation. By limiting the notice requirement to creditors with significant outstanding amounts, the company can focus its communication efforts accordingly.

Regulatory Compliance

In adherence to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jupiter LifeLine Hospitals has disclosed this development to the stock exchanges.

Next Steps

The company has stated that the details of the order will be made available on its official website, www.jupiterhospital.com , under the investor relations section.

As the amalgamation process moves forward, investors and stakeholders may want to monitor further announcements from Jupiter LifeLine Hospitals regarding the progress of the scheme and any additional regulatory approvals or steps that may be required to complete the merger.

This corporate action reflects Jupiter LifeLine Hospitals' strategic moves in the healthcare sector, potentially aimed at consolidating its market position and optimizing its operational structure.